Description

Edarbiclor (azilsartan medoxomil, chlorthalidone) Coated Tablets 40 mg/25 mg. №28

Ingredients:

Each coated tablet contains 40 mg of azilsartan medoxomil and 25 mg of chlorthalidone.

Dosage:

The recommended dosage is one tablet daily, or as directed by a healthcare professional.

Indications:

Edarbiclor tablets are indicated for the treatment of hypertension to lower blood pressure.

Contraindications:

Do not use Edarbiclor if you are allergic to any of the ingredients, pregnant, or have severe renal impairment.

Directions:

Swallow the tablet whole with water, with or without food, at the same time each day.

Scientific Evidence:

Studies have shown that the combination of azilsartan medoxomil and chlorthalidone in Edarbiclor tablets is effective in lowering blood pressure in patients with hypertension. Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) that works by relaxing blood vessels, while chlorthalidone is a diuretic that helps the body remove excess salt and water.

Clinical trials have demonstrated the superior efficacy of azilsartan medoxomil in reducing blood pressure compared to other ARBs, and the addition of chlorthalidone further enhances the antihypertensive effects of the medication.

Additional Information:

It is important to monitor blood pressure regularly while taking Edarbiclor tablets and report any significant changes to your healthcare provider. Avoid consuming alcohol while on this medication as it may increase the risk of low blood pressure.

If you experience any severe side effects such as dizziness, fainting, or difficulty breathing, seek immediate medical attention.